EUVIMEDEUVIMED entdecken
Editorial

JAK Inhibition Immunotherapy for APS-1

Maureen A Su iD

New England Journal of Medicine · 2024

DOI: 10.1056/nejme2403419 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Maureen A Su. Beteiligte Einrichtung: From the Department of Microbiology, Immunology, and Molecular Genetics and the Department of Pediatrics, David Geffen School of Medicine at Universi…. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Polyendocrinopathies, Autoimmune. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This editorial describes the science behind a study of the mechanism and treatment of autoimmune polyendocrine syndrome type 1 (also known as APECED), which is caused by damaging variants in the gene AIRE .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase InhibitorsPolyendocrinopathies, AutoimmuneFemaleHumansMaleAutoantibodiesImmunotherapyPyrazolesPyrimidinesDisease Models, AnimalAIRE ProteinNitriles

Substanzen

AutoantibodiesJanus Kinase InhibitorsPyrazolesPyrimidinesAIRE ProteinAIRE protein, humanruxolitinibNitriles

Autor:innen und Institutionen

  • From the Department of Microbiology, Immunology, and Molecular Genetics and the Department of Pediatrics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles.

ORCID-Profile: Maureen A Su

Zitieren

APA

Su, M. A. (2024). JAK Inhibition Immunotherapy for APS-1. New England Journal of Medicine. https://doi.org/10.1056/nejme2403419

Vancouver

Su MA. JAK Inhibition Immunotherapy for APS-1. New England Journal of Medicine. 2024. doi:10.1056/nejme2403419

BibTeX
@article{Su2024,
  author = {Su, Maureen A},
  title = {JAK Inhibition Immunotherapy for APS-1},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejme2403419}
}
Kostenlos starten →